Clinical Trial Update: Circulating Immune Markers for Prognostic Evaluation in Postoperative Lung Cancer Patients

View source ↗

Summary

A clinical trial is examining circulating immune markers as prognostic indicators in postoperative lung cancer patients. The study status is NOT_YET_RECRUITING.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Lung Cancer

Snippet

Sponsor: Zhao Jun | Conditions: Lung Cancer (Diagnosis), Biomarkers / Blood | Status: NOT_YET_RECRUITING